Brain Outcomes in Runted Piglets: A Translational Model of Fetal Growth Restriction

Kirat K Chand1, Kerstin Pannek2, Paul B Colditz1,3

  • 1UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Insights

Fetal growth restriction (FGR) causes long-term brain issues in newborns. The FGR piglet model offers a unique way to study these brain changes and develop new therapies.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Animal Models

Background:

  • Fetal growth restriction (FGR) is linked to lasting neurodevelopmental problems in children.
  • Current understanding of FGR's impact on the newborn brain is limited, with no available protective interventions.
  • Effective therapies require understanding the mechanisms of brain injury in FGR.

Purpose of the Study:

  • To review the utility of the piglet as an animal model for studying FGR-induced brain alterations.
  • To compare brain outcomes in human and piglet FGR models using MRI and histology.
  • To highlight the potential of the FGR piglet model for developing neuroprotective strategies.

Main Methods:

  • Review of existing literature comparing human and piglet FGR brain outcomes.
  • Analysis of magnetic resonance imaging (MRI) and histological data from FGR piglets and human neonates.
  • Discussion of the spontaneous occurrence of FGR in piglets and its relevance.

Main Results:

  • FGR piglets spontaneously develop asymmetrical growth restriction with brain sparing, mirroring human FGR.
  • Similarities in brain structural and functional changes are observed between FGR humans and piglets.
  • The piglet model allows for the study of brain injury mechanisms without confounding experimental interventions.

Conclusions:

  • The FGR piglet is a clinically relevant animal model for investigating perinatal brain injury.
  • This model provides a platform to uncover mechanisms of FGR-related neurodevelopmental disabilities.
  • Findings from FGR piglet studies can accelerate the translation of neuroprotective therapies to clinical practice.

Related Concept Videos